These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 23293330)

  • 1. Clinical Review: Nonalcoholic fatty liver disease: a novel cardiometabolic risk factor for type 2 diabetes and its complications.
    Targher G; Byrne CD
    J Clin Endocrinol Metab; 2013 Feb; 98(2):483-95. PubMed ID: 23293330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ectopic fat, insulin resistance, and nonalcoholic fatty liver disease: implications for cardiovascular disease.
    Byrne CD; Targher G
    Arterioscler Thromb Vasc Biol; 2014 Jun; 34(6):1155-61. PubMed ID: 24743428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NAFLD: a multisystem disease.
    Byrne CD; Targher G
    J Hepatol; 2015 Apr; 62(1 Suppl):S47-64. PubMed ID: 25920090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic fatty liver disease and vascular risk.
    Bhatia LS; Curzen NP; Byrne CD
    Curr Opin Cardiol; 2012 Jul; 27(4):420-8. PubMed ID: 22596186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between resistin +299A/A genotype and nonalcoholic fatty liver disease in Chinese patients with type 2 diabetes mellitus.
    Zhang LY; Jin YJ; Jin QS; Lin LY; Zhang DD; Kong LL
    Gene; 2013 Oct; 529(2):340-4. PubMed ID: 23954219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes and nonalcoholic Fatty liver disease: a pathogenic duo.
    Williams KH; Shackel NA; Gorrell MD; McLennan SV; Twigg SM
    Endocr Rev; 2013 Feb; 34(1):84-129. PubMed ID: 23238855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extrahepatic Diseases and NAFLD: The Triangular Relationship between NAFLD, Type 2-Diabetes and Dysbiosis.
    Scorletti E; Byrne CD
    Dig Dis; 2016; 34 Suppl 1():11-8. PubMed ID: 27548822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus.
    Targher G; Lonardo A; Byrne CD
    Nat Rev Endocrinol; 2018 Feb; 14(2):99-114. PubMed ID: 29286050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular and systemic risk in nonalcoholic fatty liver disease - atherosclerosis as a major player in the natural course of NAFLD.
    Lonardo A; Sookoian S; Chonchol M; Loria P; Targher G
    Curr Pharm Des; 2013; 19(29):5177-92. PubMed ID: 23432668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of prevalence of nonalcoholic fatty liver disease (NAFLD) in type 2 diabetes patients in India (SPRINT).
    Kalra S; Vithalani M; Gulati G; Kulkarni CM; Kadam Y; Pallivathukkal J; Das B; Sahay R; Modi KD
    J Assoc Physicians India; 2013 Jul; 61(7):448-53. PubMed ID: 24772746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and management of nonalcoholic fatty liver disease and its hemostatic/thrombotic and vascular complications.
    Targher G; Byrne CD
    Semin Thromb Hemost; 2013 Mar; 39(2):214-28. PubMed ID: 23397556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic fatty liver disease and type 2 diabetes: common pathophysiologic mechanisms.
    Saponaro C; Gaggini M; Gastaldelli A
    Curr Diab Rep; 2015 Jun; 15(6):607. PubMed ID: 25894944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cardiovascular link to nonalcoholic fatty liver disease: a critical analysis.
    Pacana T; Fuchs M
    Clin Liver Dis; 2012 Aug; 16(3):599-613. PubMed ID: 22824483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complications, morbidity and mortality of nonalcoholic fatty liver disease.
    Mantovani A; Scorletti E; Mosca A; Alisi A; Byrne CD; Targher G
    Metabolism; 2020 Oct; 111S():154170. PubMed ID: 32006558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonalcoholic Fatty Liver Disease: The New Complication of Type 2 Diabetes Mellitus.
    Bril F; Cusi K
    Endocrinol Metab Clin North Am; 2016 Dec; 45(4):765-781. PubMed ID: 27823604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic fatty liver disease - A multisystem disease?
    Mikolasevic I; Milic S; Turk Wensveen T; Grgic I; Jakopcic I; Stimac D; Wensveen F; Orlic L
    World J Gastroenterol; 2016 Nov; 22(43):9488-9505. PubMed ID: 27920470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concurrent nonalcoholic fatty liver disease and type 2 diabetes: diagnostic and therapeutic considerations.
    Arrese M; Barrera F; Triantafilo N; Arab JP
    Expert Rev Gastroenterol Hepatol; 2019 Sep; 13(9):849-866. PubMed ID: 31353974
    [No Abstract]   [Full Text] [Related]  

  • 18. [Analysis of metabolic risk factors for developing nonalcoholic fatty liver in patients with type 2 diabetes mellitus].
    Guo M; Xi G; Yang N; Yao H
    Zhonghua Gan Zang Bing Za Zhi; 2014 Aug; 22(8):631-5. PubMed ID: 25243967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extrahepatic complications of nonalcoholic fatty liver disease.
    Armstrong MJ; Adams LA; Canbay A; Syn WK
    Hepatology; 2014 Mar; 59(3):1174-97. PubMed ID: 24002776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.
    Streba LA; Vere CC; Rogoveanu I; Streba CT
    World J Gastroenterol; 2015 Apr; 21(14):4103-10. PubMed ID: 25892859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.